Percheron Therapeutics Ltd
Percheron Therapeutics Ltd is a commercial entity name for which no verifiable brand evidence was supplied.
Last updated October 30, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
The supplied evidence does not contain any information about Percheron Therapeutics Ltd. The two snippets provided concern unrelated subjects: a Chicago television station (FOX 32 / WFLD) and a USDA food recall by City Foods, Inc. of corned beef and pastrami products. Neither source mentions Percheron Therapeutics Ltd, its products, ownership, headquarters, or history. Because no official-site, Wikipedia, or other brand-sense evidence was supplied, this entry cannot be written as a substantive brand dossier without risking fabrication. The name suggests a therapeutics or biotechnology company, but that inference is not supported by the evidence and is therefore not asserted here. This record is flagged for review so that verified sources can be attached before the dossier is expanded.
Recent events
Percheron Therapeutics appoints Michael Baker as CEO[3]
Reported:
Percheron Therapeutics appointed Dr Michael Baker as managing director and chief executive officer. He is due to take up the role on October 5, 2026, succeeding Dr James Garner.
James Garner to step down as Percheron CEO[3]
Reported:
Dr James Garner will step down as CEO and managing director of Percheron Therapeutics on August 31, 2026, and pursue a new professional opportunity overseas. He will remain on the company's board as a non-executive director from September 1.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/percheron-therapeutics-ltd · Editorial policy · How profiles are compiled